CFCThe Compounder Score
KALY logo

KALY — Kali, Inc.

Drug Manufacturers - Specialty & GenericHealthcare

$0.00

+$0.00 (+0.00%)

Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses. It provides pharmaceuticals, cannabis extracts, and health and wellness products.

Market Cap

$101824.00

Forward P/E

N/A

52-Week Range

N/A

KALY Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)
No multi-period statement data available for this ticker yet.

Free Cash Flow

Annual. FCF margin is shown under each year.

No cash flow statement data available for this ticker yet.

Return on Capital Employed (ROCE)

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

No balance sheet data available to compute ROCE for this ticker yet.

Total Assets vs. Total Liabilities

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities
No balance sheet data available for this ticker yet.

CapEx as % of Revenue

Annual. Green at or under the 5% maximum target, red above it.

No cash flow statement data available for this ticker yet.

Shares Outstanding

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).

No share-count history available for this ticker yet.